V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20166512 | 20063679 | 1.8 | 60.55 | Palliative (P) | 2017-10-13 | 2017-10-13 | ECX | 2 | N | ECX | 100807422 |
| 20166518 | 20063680 | 1.62 | 75.3 | Neo-adjuvant (N) | 2018-02-26 | 2018-03-10 | ECX | 02 | N | ECX | 100623333 |
| 20166520 | 20063681 | 1.74 | 86.3 | Neo-adjuvant (N) | 2016-09-08 | 2016-09-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101364508 |
| 20166522 | 20063682 | 1.75 | 66.3 | Neo-adjuvant (N) | 2016-04-28 | 2016-05-10 | ECX | N | N | ECX | 101371308 |
| 20166524 | 20063683 | 1.7 | 60.8 | Neo-adjuvant (N) | 2018-07-20 | 2018-07-27 | ECX | N | N | ECX | 100558145 |
| 20166525 | 20063684 | 1.57 | 58.5 | Neo-adjuvant (N) | 2016-11-07 | 2016-11-17 | ECX | N | N | ECX | 100310203 |
| 20166531 | 20063685 | 1.57 | 95 | Neo-adjuvant (N) | 2017-11-04 | 2017-11-07 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100557318 |
| 20166542 | 20063686 | 1.61 | 80.7 | Adjuvant (A) | 2019-09-29 | 2019-09-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101687626 |
| 20166549 | 20063687 | 1.55 | 89.4 | Neo-adjuvant (N) | 2019-10-15 | 2019-10-20 | ECX | 2 | N | ECX | 100553217 |
| 20166563 | 20063688 | null | null | Adjuvant (A) | 2016-12-19 | 2016-12-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100770833 |
| 20166568 | 20063689 | 1.84 | 67 | Adjuvant (A) | 2018-09-26 | 2018-10-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100893122 |
| 20166569 | 20063690 | 1.62 | 59.25 | Neo-adjuvant (N) | 2018-12-21 | 2018-12-28 | CAPECITABINE + GEMCITABINE | N | N | ECX | 101103492 |
| 20166570 | 20063691 | 1.96 | 57.5 | Neo-adjuvant (N) | 2018-09-16 | 2018-09-17 | ECX | 2 | N | ECX | 100468142 |
| 20166572 | 20063692 | 1.72 | 70 | Palliative (P) | 2016-12-14 | 2016-12-14 | ECX | 02 | N | ECX | 100645018 |
| 20166573 | 20063693 | 1.76 | 79.8 | Palliative (P) | 2018-12-24 | 2019-01-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100275882 |
| 20166577 | 20063694 | 1.64 | 59.8 | Palliative (P) | 2018-01-31 | 2018-02-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100020956 |
| 20166579 | 20063695 | 1.79 | 80.3 | Neo-adjuvant (N) | 2019-12-09 | 2019-12-18 | ECX | 02 | N | ECX | 101202329 |
| 20166585 | 20063696 | 1.69 | 68.95 | Palliative (P) | 2018-03-02 | 2018-03-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100372130 |
| 20166587 | 20063697 | 1.64 | 55.8 | Palliative (P) | 2019-12-01 | 2019-12-29 | ECX | N | N | ECX | 101336895 |
| 20166589 | 20063698 | 1.68 | 62 | Palliative (P) | 2016-12-13 | 2017-01-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101275590 |
| 20166592 | 20063699 | 1.65 | 80.8 | Curative (C) | 2019-05-22 | 2019-05-29 | ECX | null | null | ECX | 100373795 |
| 20166596 | 20063700 | 1.54 | 65.5 | Palliative (P) | 2018-01-28 | 2018-02-13 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101787558 |
| 20166597 | 20063701 | 1.73 | 66.6 | Adjuvant (A) | 2018-05-31 | 2018-06-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100414502 |
| 20166601 | 20063702 | 1.63 | 66.9 | Neo-adjuvant (N) | 2016-04-10 | 2016-04-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101441138 |
| 20166620 | 20063703 | 1.6 | 73.8 | Neo-adjuvant (N) | 2019-12-30 | 2020-01-10 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101843564 |
| 20166627 | 20063704 | 1.71 | 72.1 | Adjuvant (A) | 2016-04-27 | 2016-05-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101191422 |
| 20166629 | 20063705 | 1.51 | 89.6 | null | 2016-12-21 | 2016-12-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100046355 |
| 20166637 | 20063706 | 1.76 | 74.2 | Neo-adjuvant (N) | 2017-08-07 | 2017-08-19 | ECX | 2 | N | ECX | 100831848 |
| 20166638 | 20063707 | 1.72 | 47.8 | Adjuvant (A) | 2019-03-20 | 2019-04-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101686489 |
| 20166639 | 20063708 | 1.69 | 77 | Palliative (P) | 2016-09-25 | 2016-10-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101267345 |
| 20166644 | 20063709 | 1.75 | 86.4 | Adjuvant (A) | 2017-06-21 | 2017-06-21 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100476747 |
| 20166646 | 20063710 | 1.63 | 59.2 | Neo-adjuvant (N) | 2018-02-16 | 2018-02-16 | ECX | 02 | N | ECX | 100672795 |
| 20166647 | 20063711 | 1.75 | 90 | Curative (C) | 2016-03-23 | 2016-04-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101559406 |
| 20166654 | 20063712 | 1.56 | 46 | Adjuvant (A) | 2017-05-19 | 2017-06-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101730596 |
| 20166659 | 20063713 | 1.76 | 75.2 | Palliative (P) | 2020-01-02 | 2020-01-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101686904 |
| 20166660 | 20063714 | 1.66 | 62 | Palliative (P) | 2016-06-05 | 2016-06-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101026907 |
| 20166666 | 20063715 | 1.81 | 62 | Neo-adjuvant (N) | 2018-12-21 | 2018-12-21 | ECX | N | N | ECX | 101781743 |
| 20166672 | 20063716 | 1.86 | 60.7 | Curative (C) | 2019-09-20 | 2019-10-05 | ECX | 2 | N | ECX | 101385105 |
| 20166676 | 20063717 | 1.59 | 66 | null | 2019-05-18 | 2019-05-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100335282 |
| 20166678 | 20063718 | 1.78 | 91 | Adjuvant (A) | 2017-01-07 | 2017-01-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101260258 |
| 20166679 | 20063719 | 1.64 | 62.4 | Palliative (P) | 2016-07-23 | 2016-09-01 | ECX | null | N | ECX | 101749245 |
| 20166684 | 20063720 | 1.7 | 93.6 | Palliative (P) | 2018-02-05 | 2018-02-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100514953 |
| 20166688 | 20063721 | 1.62 | 80.2 | Neo-adjuvant (N) | 2018-05-25 | 2018-06-01 | ECX | 2 | N | ECX | 100347788 |
| 20166690 | 20063722 | 1.77 | 98.4 | Palliative (P) | 2018-05-15 | 2018-06-11 | ECX | N | N | ECX | 100854045 |
| 20166700 | 20063723 | 1.56 | 53.2 | Adjuvant (A) | null | null | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101315836 |
| 20166701 | 20063724 | 1.8 | 68.1 | null | 2017-11-26 | 2017-12-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100120439 |
| 20166716 | 20063725 | 1.6 | 69.7 | Neo-adjuvant (N) | 2016-04-22 | 2016-04-24 | ECX | 2 | N | ECX | 100418702 |
| 20166724 | 20063726 | 1.74 | 79 | Adjuvant (A) | 2017-02-26 | 2017-03-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100856303 |
| 20166729 | 20063727 | 1.75 | 95.7 | Neo-adjuvant (N) | 2019-06-30 | 2019-07-14 | ECX | 02 | null | ECX | 101196097 |
| 20166732 | 20063728 | 1.77 | 82.3 | Palliative (P) | 2017-04-25 | 2017-04-25 | ECX | 02 | N | ECX | 101488712 |